1-(4-carboxyphenyl)-3,3-dimethyltriazene has been researched along with razoxane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giraldi, T; Grill, V; Mallardi, F; Perissin, L; Zorzet, S | 1 |
| Cherubino, R; Giraldi, T; Mitri, E; Sava, G | 1 |
| Cuman, R; Giraldi, T; Lassiani, L; Nisi, C; Sava, G | 1 |
3 other study(ies) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and razoxane
| Article | Year |
|---|---|
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
Topics: Animals; Dacarbazine; Hemorrhage; Lung Neoplasms; Mice; Neoplasm Metastasis; Piperazines; Razoxane; Triazenes | 1987 |
Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Tests; Cyclophosphamide; Dacarbazine; Female; Fibrinogen; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Piperazines; Platelet Aggregation; Platelet Count; Razoxane; Triazenes | 1984 |
Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Piperazines; Razoxane; Thymidine; Time Factors; Triazenes | 1981 |